Back to Search
HORACIO PLOTKIN, MD
MD
Pediatric Endocrinology Physician
NPI: 1477503647Individual
Specialties, Licenses & Credentials
Endocrinology, Diabetes & Metabolism Physician
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
22264(NE)
Pediatric Endocrinology PhysicianPrimary
Pediatrics — Pediatric Endocrinology
Code: 2080P0205X
22264(NE)
Research & Publications (20)
Osteoporosis in children with neuromuscular diseases and inborn errors of metabolism.
PMID 17404563·Minerva Pediatr·2007
6-review
Surgical treatment of osteogenesis imperfecta: current concepts.
PMID 18197039·Curr Opin Pediatr·2008
6-review
International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions.
PMID 18793764·Bone·2008
8-other
Special report on the 2007 adult and pediatric Position Development Conferences of the International Society for Clinical Densitometry.
PMID 18633664·Osteoporos Int·2008
8-other
Special report on the 2007 Pediatric Position Development Conference of the International Society for Clinical Densitometry.
PMID 18580718·South Med J·2008
6-review
Low doses of pamidronate to treat osteopenia in children with severe cerebral palsy: a pilot study.
PMID 16904014·Dev Med Child Neurol·2006
3-trial
Bone health in Duchenne muscular dystrophy: a workshop report from the meeting in Cincinnati, Ohio, July 8, 2004.
PMID 15639125·Neuromuscul Disord·2005
8-other
Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone.
PMID 14557424·J Clin Endocrinol Metab·2003
8-other
Rapid increase in grip force after start of pamidronate therapy in children and adolescents with severe osteogenesis imperfecta.
PMID 12728117·Pediatrics·2003
8-other
Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV.
PMID 12728084·Pediatrics·2003
8-other
We-intentionality: an essential element in understanding human culture?
PMID 12721526·Perspect Biol Med·2003
8-other
Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy.
PMID 12674321·J Bone Miner Res·2003
8-other
Osteogenesis imperfecta types I, III, and IV: effect of pamidronate therapy on bone and mineral metabolism.
PMID 12629073·J Clin Endocrinol Metab·2003
8-other
The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta.
PMID 12417568·J Clin Invest·2002
8-other
Bone mineralization in polyostotic fibrous dysplasia: histomorphometric analysis.
PMID 12412801·J Bone Miner Res·2002
8-other
Comparable bioavailability of two esophago-gastric protective formulations containing pamidronate. A cross-over trial in healthy young adults.
PMID 12325487·Medicina (B Aires)·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 500 KENDALL ST, GENZYME CORPORATION
CAMBRIDGE, MA 02142 - Phone
- (617) 768-4345
Quick Facts
- NPI
- 1477503647
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile